Rezultati - Katharina Modelska

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials

    Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials od Katharina Modelska, Steven R. Cummings

    Izdano 2002
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial

    Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial od Moshe Mittelman, David H. Henry, John A. Glaspy, Anıl Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer od Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal D. Shore, Ubirajara Ferreira, Petro Ivashchenko, Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N. Sternberg

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study

    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study od David H. Henry, John A. Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E. Carraway, Charles W. Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin‐Hung P. Yu

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region

    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of... od Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, Ugo De Giorgi, Eleni Efstathiou, Ubirajara Ferreira, Petro Ivashchenko, Katarzyna Madziarska, Mohammed Al-Adhami, Katharina Modelska, D. Phung, Joyce Steinberg, Cora N. Sternberg

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer od Cora N. Sternberg, Karim Fizazi, Fred Saad, Neal D. Shore, Ugo De Giorgi, David F. Penson, Ubirajara Ferreira, Eleni Efstathiou, Katarzyna Madziarska, Michael Paul Kolinsky, Daniel de Iracema Gomes Cubero, Bettina Noerby, Fabian Zohren, Xun Lin, Katharina Modelska, Jennifer Sugg, Joyce Steinberg, Maha Hussain

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: